Sean Moran
Chief Financial Officer @Corbus Pharmaceuticals
Signup · Get unlimited contacts
WORK HISTORY
Chief Financial Officer @Corbus Pharmaceuticals
Corbus Pharmaceuticals Holdings, Inc.(the “Company” or “Corbus”) is a precision oncology company committed to helping people defeat serious illness by bringing innovative scientific approaches to well understood biological pathways. Corbus’ internal development pipeline includes CRB-701, a next generation antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. The Company has also developed CRB-913, an endocannabinoid small molecule drug, for the treatment of obesity and is seeking partners to fund further development.
EDUCATION
Babson College
Bachelor of Science, Accounting
Babson F.W. Olin Graduate School of Business
Master of Business Administration (MBA), Finance
SKILLS
ABOUT SEAN MORAN
An innovative CFO with an entrepreneurial spirit and a demonstrated record of achievement…
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.